Result Summary for 113211
| Protocol ID: | 113211 |
| Clinical Study ID: | NKG113211 |
| Official Title: | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD) |
| Phase: | phase 2 |
| Study Indications or Diseases: |
|
| Generic Name: | orvepitant |
| Trade/Product Name: | Not applicable |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
